Mitsubishi UFJ Trust & Banking Corp lessened its holdings in Humana Inc. (NYSE:HUM - Free Report) by 19.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 63,594 shares of the insurance provider's stock after selling 15,688 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp owned 0.05% of Humana worth $16,134,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Transcend Capital Advisors LLC grew its position in Humana by 399.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock worth $924,000 after purchasing an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC grew its holdings in shares of Humana by 6,647.5% during the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock valued at $6,916,000 after buying an additional 26,856 shares during the last quarter. Retirement Systems of Alabama increased its position in shares of Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after acquiring an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Humana by 7.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock worth $244,811,000 after acquiring an additional 65,735 shares during the last quarter. Finally, PDT Partners LLC grew its stake in Humana by 190.0% during the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock valued at $1,286,000 after purchasing an additional 2,660 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.
Humana Stock Down 0.5 %
Shares of Humana stock traded down $1.24 during trading hours on Wednesday, reaching $263.50. 225,895 shares of the company were exchanged, compared to its average volume of 1,750,093. The firm has a market cap of $31.80 billion, a PE ratio of 26.49, a PEG ratio of 2.05 and a beta of 0.57. The stock's fifty day moving average is $269.37 and its 200 day moving average is $272.67. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.
Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.
Humana Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. Humana's payout ratio is currently 35.58%.
Analysts Set New Price Targets
A number of equities analysts have issued reports on HUM shares. JPMorgan Chase & Co. reduced their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Truist Financial upped their price target on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a report on Monday, January 6th. Morgan Stanley reduced their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 12th. Piper Sandler boosted their price target on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Eighteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Humana has an average rating of "Hold" and an average target price of $285.68.
Read Our Latest Analysis on HUM
Humana Company Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
